Skip to main content
2024 Guide to Patient Support Services

Blueprint Medicines

2024 PSS Guide

Blueprint Medicines Support Services

Blueprint Medicines offers the YourBlueprint patient support program to provide appropriate information and assistance to patients taking Ayvakit (Table).


YourBlueprint patient support program offers a QuickStart Program, Coverage Interruption Program, Ayvakit Dose Exchange Program, Co-pay Assistance Program, Patient Assistance Program, as well as a team of case managers, reimbursement specialists, and specialty pharmacy liaisons to assist your patients access treatment.

QuickStart Program

This program offers a temporary no-cost 15-day supply of medication in the event of a coverage-related delay.

Coverage Interruption Program

This program offers a no-cost 15-day supply of medication to patients already on therapy who face a temporary interruption in insurance coverage.

Ayvakit Dose Exchange Program

This program allows patients who have a change in their dose of Ayvakit to exchange remaining medication for the new dose.

Co-pay Assistance Program

Patients may be eligible for the Co-pay Assistance Program if they have commercial insurance with coverage for their prescription.

Patient Assistance Program

Patients may be eligible for the Patient Assistance Program if they meet certain financial and eligibility criteria.

To learn more or to enroll your patient in YourBlueprint, call 888-258-7768 or visit Patient Assistance Program.

TABLE Blueprint Oncology Drug

Patient support programs

Ayvakit (avapritinib) tablets
Treatment of adults with unresectable or metastatic gastrointestinal stromal tumor harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutations; treatment of adult patients with advanced systemic mastocytosis to include aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast-cell leukemia; treatment of adult patients with indolent systemic mastocytosis
Patient support programs